Supaglutide
A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1)
Shanghai Yinnuo Pharmaceutical Technology Co. · Phase 2/3 · Completed · Enrollment 547
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Supaglutide RP3D high dose | T2D only | n/r | n/r | n/r | n/r |
| supaglutide RD3D Low dose | T2D only | n/r | n/r | n/r | n/r |
| placebo | T2D only | n/r | n/r | n/r | n/r |